Cometriq 80 mg Alternative – Caboxen (Cabozantinib) 80 mg Capsule | Everest Pharmaceuticals
Caboxen 80 mg (Cabozantinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Cometriq (Exelixis). It belongs to the multikinase inhibitor class and is used in selected medullary thyroid cancer settings for capsule formulations; other cabozantinib formulations have different approved uses.
Active ingredient: Cabozantinib
Strength: 80 mg
Form: Capsule
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Doptelet 20 mg Alternative – Avapag (Avatrombopag) 20 mg Tablet | Everest Pharmaceuticals
Avapag 20 mg (Avatrombopag) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Doptelet (Sobi / Dova). It belongs to the thrombopoietin receptor agonist class and is used in selected thrombocytopenia associated with chronic liver disease procedures or immune thrombocytopenia.
Active ingredient: Avatrombopag
Strength: 20 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Erleada 60 mg Alternative – Apaluda (Apalutamide) 60 mg Tablet | Beacon Pharmaceuticals
Erleada 60 mg Alternative – Prostaxen (Apalutamide) 60 mg Tablet | Everest Pharmaceuticals
Prostaxen 60 mg (Apalutamide) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Erleada (Janssen). It belongs to the androgen receptor inhibitor class and is used in selected castration-resistant or castration-sensitive prostate cancer settings.
Active ingredient: Apalutamide
Strength: 60 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Evrenzo 100 mg Alternative – Renofix (Roxadustat) 100 mg Tablet | Everest Pharmaceuticals
Renofix 100 mg (Roxadustat) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Evrenzo (Astellas). It belongs to the HIF-prolyl hydroxylase inhibitor class and is used in anemia associated with chronic kidney disease in jurisdictions where authorized.
Active ingredient: Roxadustat
Strength: 100 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Evrenzo 20 mg Alternative – Renofix (Roxadustat) 20 mg Tablet | Everest Pharmaceuticals
Renofix 20 mg (Roxadustat) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Evrenzo (Astellas). It belongs to the HIF-prolyl hydroxylase inhibitor class and is used in anemia associated with chronic kidney disease in jurisdictions where authorized.
Active ingredient: Roxadustat
Strength: 20 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Evrenzo 50 mg Alternative – Renofix (Roxadustat) 50 mg Tablet | Everest Pharmaceuticals
Renofix 50 mg (Roxadustat) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Evrenzo (Astellas). It belongs to the HIF-prolyl hydroxylase inhibitor class and is used in anemia associated with chronic kidney disease in jurisdictions where authorized.
Active ingredient: Roxadustat
Strength: 50 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Evrenzo 70 mg Alternative – Renofix (Roxadustat) 70 mg Tablet | Everest Pharmaceuticals
Renofix 70 mg (Roxadustat) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Evrenzo (Astellas). It belongs to the HIF-prolyl hydroxylase inhibitor class and is used in anemia associated with chronic kidney disease in jurisdictions where authorized.
Active ingredient: Roxadustat
Strength: 70 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Exjade 250 mg Alternative – Deferox (Deferasirox) 250 mg Tablet | Beacon Pharmaceuticals
Exjade 500 mg Alternative – Deferox (Deferasirox) 500 mg Tablet | Beacon Pharmaceuticals
Femara 2.5 mg Alternative – Femroz (Letrozole) 2.5 mg | Everest Pharmaceuticals
Femroz 2.5 mg by Everest Pharmaceuticals Ltd., Bangladesh, contains letrozole 2.5 mg, the same active ingredient and strength as the originator brand Femara 2.5 mg (Novartis). It is a prescription aromatase inhibitor used in the hormonal treatment of certain breast cancers in postmenopausal women.
Originator reference: Femara (Novartis)
Listed alternative brand: Femroz (Everest Pharmaceuticals)
Generic: Letrozole 2.5 mg
Form: Oral tablet
Prescription: Required
Shared ingredients and strength do not establish bioequivalence or automatic interchangeability. Any substitution must be approved by a qualified healthcare professional.